GlassScriptPhysician profile
Laila B Needham
NPI 1528241700
$1,301.97
in general payments reported to CMS, 2019-2025
25 companies · $80.62 in 2025
The $80.62 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $39.82 · 2021: $265 · 2022: $233 · 2023: $250 · 2024: $244 · 2025: $80.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $185.62 | 2019-2022 | |
| Astellas Pharma US INC | $180.93 | 2020-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $137.42 | 2019-2025 | |
| Coopersurgical, INC. | $124.00 | 2021-2025 | Summit Doppler, Paragard T 380a, Paragard T 380a |
| Mayne Pharma Commercial LLC | $91.96 | 2021-2022 | |
| Hologic Sales and Service, LLC | $86.44 | 2021-2024 | Novasure, Acessa Provu System, Myosure Tissue Removal Device |
| Exeltis, USA INC. | $60.57 | 2021-2024 | Slynd |
| Therapeuticsmd, INC. | $51.12 | 2019-2022 | |
| Heron Therapeutics, INC. | $45.01 | 2022 | |
| Avion Pharmaceuticals | $36.24 | 2019-2022 | |
| Optumhealth Care Solutions, LLC | $34.19 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Myovant Sciences INC. | $33.57 | 2021-2022 | |
| Lsi Solutions INC | $32.61 | 2023-2025 | Fornisee |
| Organon LLC | $27.80 | 2022-2024 | |
| Pfizer INC. | $25.43 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $18.15 | 2024 | |
| Scynexis, INC. | $17.89 | 2022 | |
| Amgen INC. | $16.33 | 2019 | |
| Novo Nordisk INC | $15.74 | 2023 | Wegovy |
| Kci USA, INC. | $15.57 | 2023 | Prevena |
| Medtronic, INC. | $15.08 | 2021 | |
| Agile Therapeutics, INC. | $13.52 | 2024 | Twirla |
| Duchesnay USA Incorporated | $13.02 | 2019 | |
| Minerva Surgical, INC | $12.75 | 2021 | |
| Boston Scientific Corporation | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laila Needham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.